Chugh, S., Tien, J. C., Hon, J., Kenum, C., Mannan, R., Cheng, Y., . . . Chinnaiyan, A. M. Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma. Elsevier.
Chicago Style (17th ed.) CitationChugh, Seema, et al. Therapeutic Benefit of the Dual ALK/FAK Inhibitor ESK440 in ALK-driven Neuroblastoma. Elsevier.
MLA (9th ed.) CitationChugh, Seema, et al. Therapeutic Benefit of the Dual ALK/FAK Inhibitor ESK440 in ALK-driven Neuroblastoma. Elsevier.
Warning: These citations may not always be 100% accurate.